Biological production of inorganic materials is impeded by relatively few organisms possessing 10 genetic and metabolic linkage to material properties. The physiology of electroactive bacteria is 11 intimately tied to inorganic transformations, which makes genetically tractable and well-studied 12 electrogens, such as Shewanella oneidensis, attractive hosts for material synthesis. Notably, this 13 species is capable of reducing a variety of transition-metal ions into functional nanoparticles, but 14 exact mechanisms of nanoparticle biosynthesis remain ill-defined. We report two key factors of 15 extracellular electron transfer by S. oneidensis, the outer membrane cytochrome, MtrC, and 16 soluble redox shuttles (flavins), that affect Pd nanoparticle formation. Changes in the expression 17 and availability of these electron transfer components drastically modulated particle phenotype, 18 including particle synthesis rate, structure, and cellular localization. These relationships may 19 serve as the basis for biologically tailoring Pd nanoparticle catalysts and could potentially be used 20 to direct the biogenesis of other metal nanomaterials. 21 22 transfer, and vesicle formation to generate size-controlled magnetite nanoparticles 8 . This example 36 highlights the capability of living systems to tailor inorganic structure-function relationships and 37 suggests that exploiting naturally-occurring pathways may provide a means for designer material 38 biosynthesis.
Introduction

23
Control over cellular machinery has enabled the production of diverse compounds including 24 pharmaceuticals, fuels, fine chemicals, and soft materials 1-3 . However, microbial engineering of 25 metal and metal oxide products remains a significant challenge. Attributes such as electron 26 transfer and nucleation are typically absent from organic biosyntheses, and their presence adds 27 increased complexity to inorganic transformations. As a result, the enzymatic and metabolic 28 factors that drive material formation in biological systems have been challenging to study and 29 manipulate 4 . Despite the paucity of bioengineered inorganic products, microbial transformation of 30 inorganics occurs quite frequently in nature. Several organisms generate highly functional and 31 ordered materials, including metal nanoparticles, silicas, calcium carbonates, and metal oxides 5-32 7 . In these systems, coordinated protein and metabolite networks exert control over material 33 morphology, composition, and function. For instance, the magnetotactic bacterium, 79 supplementation, respectively, we observed drastic effects on the synthesis rate, size, and cellular 80 localization of biogenic nanoparticles. Identification of these factors provides proof-of-principle for 81 using genetic and metabolic manipulation to tune the properties of Pd and potentially other metal 82 nanoparticles generated by S. oneidensis. 
96
Choice of electron donor can greatly affect bacterial nanoparticle formation, as many 97 metabolically accessible electron donors (e.g. formate, hydrogen) also abiotically reduce 98 palladium ions 25 . Indeed, we found that the hydrogenous atmosphere (3%) of a humidified 99 anaerobic glovebox caused autocatalytic reduction of palladium in the absence of bacteria. Thus, 100 we used butyl rubber-stoppered Hungate Tubes purged with argon to maintain anaerobicity for 101 bacterial pregrowth and nanoparticle biosynthesis reactions. As lactate is relatively inert to also examined the characteristics of Pd nanoparticles formed by a hydrogenase deficient strain 138 (∆hydA∆hyaB) .
139
Noticeable differences between nanoparticle reaction mixtures containing different strains 140 were observed shortly after bacterial inoculation. Reactions inoculated with MR-1 or the 141 ∆hydA∆hyaB strain turned a diffuse black color that is characteristic of reduced Pd 27 , while those 142 with the ∆mtrC∆omcA mutant remained relatively colorless. Similarly, the cell pellets for the MR-143 1 and the ∆hydA∆hyaB strains were dark black, while the ∆mtrC∆omcA pellet appeared light grey 144 ( Figure S4 ). Whole mount TEM showed that these differences arose based on the types of 145 nanoparticles generated by each strain. The large particle population observed on MR-1 was not 146 found on the ∆mtrC∆omcA strain and only small nanoparticles were adherent to this cytochrome 147 double knockout ( Figure S5 ). In contrast, nanoparticles on the ∆hydA∆hyaB strain were identical 148 to those on MR-1, exhibiting both large and small particle populations. As whole mount TEM 149 cannot resolve the cellular location of particles, thin section TEM was performed. Thin sectioning 150 of all three strains revealed that the two populations of particles not only differ in size, but also in 151 cellular localization: smaller (<10 nm) particles localized to the periplasm and larger particle 152 aggregates (~50 nm) adhered to the outer membrane and faced the extracellular space.
153
Consistent with whole mount observations, MR-1 and the ∆hydA∆hyaB strain contained both 154 particle populations, while the ∆mtrC∆omcA strain lacked extracellular particles (Figure 1b -g, S6).
155
A similar change in UO 2 nanoparticle localization has previously been observed with this mutant 14 .
156
Across all strains, no Pd particles were detected within the bacterial cytoplasm, indicating that 157 reduction primarily occurred in the periplasm or extracellular space. Comparisons between 158 bacteria palladized at 100 and 1000 µM Pd(II) showed that more particles were produced per cell 159 at higher Pd(II) concentrations. However, nanoparticle localization was more binary at the lower 160 Pd(II) concentration. At low Pd(II) concentrations, particles exclusively nucleated extracellularly 161 on the outer membrane (MR-1, ∆hydA∆hyaB) or within the periplasm (∆mtrC∆omcA). Together, 162 our data suggests that low Pd(II) concentrations accentuate genotypic differences, whereas 163 decreased cell viability at high Pd(II) concentrations ( Figure S3 ) results in more promiscuous 164 Pd(II) reduction.
165
In addition to TEM, powder x-ray diffraction (PXRD) was used to characterize the properties 166 of bacterial Pd nanoparticles. PXRD patterns can reveal the chemical identity and relative size of 167 analyzed nanomaterials. Differences between S. oneidensis strains were detected by PXRD, and 168 corroborated trends observed by TEM ( Figure S7 ). While nanoparticles formed by MR-1 and the 169 ∆hydA∆hyaB mutant had comparable patterns, broader peaks were observed for those from the 170 Scherrer equation 28 . The observed peak locations were consistent with previous Pd-Shewanella 172 studies and with abiotic Pd(0) patterns 20 , verifying that peaks were a result of palladization. These 173 results further demonstrate the importance of outer membrane cytochromes in controlling 174 nanoparticle properties and show that PXRD can be used to distinguish genotypic differences.
175
The existence of the two particle populations illuminates how bacterial membranes and outer 176 membrane cytochromes influence nanoparticle nucleation and growth. Cellular 177 compartmentalization appears to physically constrain nanoparticle structure, as evidenced by 178 intracellular particles limited in size by periplasmic dimensions (<50 nm), while extracellular 179 particles further aggregated (>50 nm). Importantly, bacterial genotype controlled particle 180 localization, since loss of outer membrane cytochromes MtrC and OmcA was coincident with loss 181 of outer membrane particles (Figure 1c, 1f ). Nanoparticle reaction mixtures that replaced S.
182
oneidensis with a cytochrome-lacking bacterium, Escherichia coli MG1655, similarly had no large 183 extracellular particles formed on the bacteria ( Figure S8 ). Additionally, post-palladization viability 184 studies performed on MR-1 and the ∆mtrC∆omcA strain showed that changes in cell viability do 185 not account for the differences between particle phenotypes ( Figure S9 ). Together, this indicates 186 that the outer membrane cytochromes are critical for extracellular Pd nucleation and likely serve 187 as sites for electron transfer to Pd(II).
189
Loss of Outer Membrane Cytochromes Attenuates Pd(II) Reduction
190
Generally, the structures of biosynthesized metabolites are invariant to the rate at which they 191 are produced. In contrast, metal ion reduction rates can exert significant influence over the size 192 and morphology of produced nanoparticles 29 . To assess whether reduction kinetics could explain 193 differences in Pd particle size/localization between S. oneidensis strains, we quantified Pd(II) Figure S10 ). Following the 199 initial adsorption event, we measured a comparable first-order Pd(II) reduction rate between MR-200 1 and the hydrogenase deficient mutant when lactate was utilized as an electron donor (Figure 2 , 201 S11). Although kinetic differences between these strains have previously been measured when 202 utilizing formate 15 , less metabolic electron flux is directed to the quinone pool from formate 203 catabolism 30 . This suggests that the outer membrane cytochromes are primarily responsible for 204 quinone pool. Accordingly, the ∆mtrC∆omcA strain showed significantly attenuated Pd(II) 206 reduction relative to MR-1 . These results differed from a previous study, where a strain lacking 207 these cytochromes had a rate of reduction rate that was identical to MR-1 15 . We attribute these 208 conflicting observations to the significant effects that buffering capacity can exert on the kinetics 209 of Pd(II) reduction by S. oneidensis. We note that our bacterial pregrowth and nanoparticle 210 reaction mixtures utilized substantially more buffered media (100 mM HEPES) than this previous 211 study (30 mM HEPES). Even under our conditions, Pd(II) reduction rate greatly decreased with 212 increasing age of dissolved HEPES in pregrowth and reaction media ( Figure S12 ). Cell growth 213 can alter culture medium acidity, and the pH stability of strongly buffered media may counter 214 physiological shifts such as cytochrome downregulation or inactivity that otherwise occurs 31 .
215
Alternatively, the loss of MtrC and OmcA increased the variability between biological replicates, 216 which could arise from the increased role of promiscuous reductants as opposed to specific 217 electron transport pathways. This may have further obscured kinetic differences between strains 218 in previous studies. Taken together, our results are consistent with previously purported 219 nanoparticle formation mechanisms by S. oneidensis: Pd(II) adsorbs to cells, Pd(II) is reduced, 220 and Pd nanoparticles nucleate 15 . Notably, our results highlight the importance of outer membrane 221 cytochromes in the latter two steps.
223
MtrC Expression Controls Extracellular Pd Nanoparticle Formation
224
To better understand the role of MtrC and OmcA in Pd(II) reduction and nanoparticle formation, 225 we complemented the ∆mtrC∆omcA strain with one of three plasmids that was either an empty 226 control vector or vectors carrying mtrC and omcA under constitutive control 32 .
227
We first tested whether the presence of either MtrC or OmcA was sufficient to restore the 228 extracellular particle phenotype observed with MR-1. Whole mount TEM showed that 229 ∆mtrC∆omcA strains carrying either an empty vector or an omcA-expressing vector were unable 230 to form large nanoparticles that are characteristic of extracellular localization ( Figure S13 ).
231
However, large particles were observed on the double knockout strain complemented with a 232 plasmid carrying mtrC. Thin section TEM confirmed that large particles formed by this mtrC-233 complemented strain were extracellular and adherent to the bacterial outer membrane (Figure 3 , 234 S14). MR-1 carrying an empty plasmid exhibited an identical phenotype, which validated that 235 MtrC expression is responsible for extracellular particle nucleation and plasmid maintenance does 236 not interfere with nanoparticle formation. These results are consistent with previous reports that 237 describe MtrC functioning in the Mtr pathway 12 . In these studies, MtrC expression restored EET 238 to Fe(III) species in outer membrane cytochrome deficient strains, while OmcA only partially 239 contributed to EET. OmcA may act as a non-critical helper protein that requires MtrC to receive 240 electrons for subsequent metal reduction. Our results suggest that this mechanism is also true for 241 Pd(II) reduction.
242
We next measured Pd(II) reduction kinetics with the mtrC-complemented mutant to assess 243 whether wild-type Pd(II) reduction was rescued. Indeed, reduction was substantially faster with 244 the mtrC-complemented mutant relative to the same mutant carrying an empty plasmid (Figure 4 , 245 S11). Moreover, the mtrC-complemented mutant exhibited a faster Pd(II) reduction rate compared 246 to MR-1 carrying an empty plasmid. This is likely due to different MtrC expression levels between 247 our engineered strain and MR-1. Taken together with our microscopy and knockout results, our 248 complementation studies confirm that MtrC is a critical enabler of Pd(II) reduction and extracellular 
272
to OmcA and MtrC 35 , respectively, and an increase in cytochrome-binding may explain the greater 274 number of Pd nanoparticles on the outer membrane. In contrast to flavins, supplementing other 275 respiration substrates (sodium fumarate and Fe(III)-citrate) showed no effect on nanoparticle size 276 (Figure S17, S18). Additionally, we measured no effect on cell viability when supplementing with 277 flavins, which discounts the influence of stress response on affecting nanoparticle formation 278 ( Figure S19 ). These results support our hypothesis that, unlike other metabolites, flavins play a 279 role in either electron transfer to Pd(II), particle nucleation/growth, or both.
280
To further investigate this mechanism, we measured Pd(II) 
300
Notably, expression of MtrC via an engineered plasmid led to Pd(II) reduction rates that were 301 faster than wild-type controls. Given this observation, coupled with the loss of extracellular 302 particles on mtrC knockouts, we hypothesize that more fine-tuned expression of MtrC may 303 correlate to different numbers and sizes of produced nanoparticles. This strategy may also be 304 adapted to standard chassis organisms that express functional MtrC, such as engineered E. coli 305 strains 38 , or other electroactive bacteria possessing Pd(II)-reducing outer membrane cytochromes directly engineering the MtrC polypeptide sequence, either through rational or evolutionary 308 mutagenesis. Altering the redox-potential and catalytic activity of heme-containing proteins is well-309 precedented 41 , and key mutations could be applied to identify/tune the Pd(II) reduction activity of 310 MtrC hemes 42 . Additionally, a binding-site for iron oxide nanoparticles to the outer membrane 311 cytochrome, MtrF, has recently been elucidated using protease footprinting 43 , and similar 312 methods could be used to identify and affect residues involved in particle nucleation by MtrC.
313
We observed a decrease in the size of Pd nanoparticles with increasing concentration of 
406
Palladized bacteria were prepared as described above. Nanoparticle synthesis was stopped after 409 2 hours (100 µM Pd(II)) or 24 hours (1 mM Pd(II)), and cells were centrifuged/washed twice. In 410 early experiments, cells were washed with SBM containing trace metals as to minimize osmotic 411 shock, but we later found that autoclaved H 2 O could be utilized with minimal change in cell shape 412 and improved electron micrograph contrast. For whole mount TEM, washed cells were 413 concentrated to an OD 600 of ~2.7 and 5 µL was drop-cast onto glow-discharged 200 mesh carbon-414 coated copper TEM grids (Electron Microscopy Sciences). For thin section TEM, cells were fixed 415 prior to sectioning and imaging. First, a 100 mL cation stock solution was prepared that contained 416 CaCl 2 ·2H 2 O (0.3 g) and MgSO 4 ·7H 2 O (1 g). Next, aldehyde fixation solution was prepared by 417 mixing 1 mL of cation stock with 5 mL of cacodylate buffer (0.2 M, pH 7.4), 0.8 mL of 418 glutaraldehyde (50%), 1.25 mL of paraformaldehyde (16%), and 2 mL of H 2 O. The washed cell 419 pellet was resuspended in 1 mL of aldehyde fixation solution and incubated at room temperature 420 for 4 hours. After, cells were washed three times in 0.1 M cacodylate buffer. An osmium tetroxide 421 fixation solution was prepared immediately before use by mixing in a 1:1 ratio of 4% potassium 422 ferrocyanide in 0.2 M cacodylate buffer (also prepared immediately before use) and 4% osmium 423 tetroxide. The cell pellet was resuspended in 1 mL osmium textroxide fixation solution and 424 incubated for 4 hours on ice. Next, the pellet was resuspended in H 2 O for 10 minutes, spun-down, 425 and repeated until the supernatant was clear (~10 washes required). Subsequently, the pellet 426 was dehydrated in 50, 70, 95%, and 100% (twice) ethanol, for 15 minutes at each dehydration.
427
After the final 100% ethanol wash, the pellet was washed in acetone for 15 minutes, twice. Next, 428 the pellet was infiltrated with 30% epoxy resin in 100% acetone, 66% resin in 100% acetone, and 429 finally 100% resin (twice), for ~16 hours with each infiltration. Finally, the pellet was placed in 430 fresh epoxy resin, cast into a sectioning-block mold, and heated at 65 ºC for 2 days. Sectioning 431 was accomplished using a Leica UltraCut Microtome and sections were placed on copper TEM 432 grids to for imaging. Whole mount and thin section TEM was performed using a FEI Tecnai 433 Transmission Electron Microscope.
435
Pd(II) Quantification 436 Extracellular Pd(II) concentrations were primarily quantified using the colorimetric 4-(2-437 pyridylazo)-resorcinol (PAR) assay 49 , the general procedure is as follows. A 0.1% PAR stock 438 solution was freshly prepared by dissolving 25 mg PAR in 1 mL 1% NaOH, and then adding this 439 solution to 24 mL MilliQ H 2 O. A stock solution of 100 mM EDTA was also prepared and the pH quickly thawed and centrifuged at 10,000xg for 5 minutes to pellet bacteria. Next, 100 µL of each 442 reaction mixture supernatant was added to microcentrifuge tubes containing 500 µL of the 100 443 mM EDTA stock and 5 µL of the 0.1% PAR stock. This solution was heated at 80 ºC for 10 444 minutes, cooled at 4 ºC for 20 minutes, and absorbance at 515 nm was measured using a 445 CLARIOStar platereader (BMG Labtech). Standard curves were prepared in SBM containing 446 trace metals over a range of 0-125 µM Pd(II). Flavins exhibit absorbance overlapping that of PAR, 447 which obscured Pd(II) quantification using this method. Therefore, inductively coupled plasma 448 mass spectrometry (ICP-MS) was used to obtain reduction kinetics in the presence of flavins. To 449 prepare samples for ICP-MS, aliquots were thawed, centrifuged at 10,000xg for 5 minutes, and 450 the supernatant mixed in a 1:1 ratio with strong (~70%) nitric acid. Samples were further diluted 451 80-fold in weak (~2%) nitric acid to bring total dissolved solids to ppm levels and then analyzed 452 using an Agilent 7500ce ICP-MS. Pd(II) Materials, 2nd Edition, by Harold P. Klug, Leroy E. Alexander, 
